API
< Back to all clusters
[HEALTH] · Spain · 3 sources

started · updated

Spain reports supply issues for nearly 1,000 medication presentations

The Spanish Agency for Medicines and Health Products (AEMPS) has identified 918 medication presentations currently facing supply shortages across Spain. Recent incidents reported between November 1 and November 6 include drugs such as Lercanidipine Normon, Metoclopramide Basi, Minoxidil Cinfa, Simbrinza, Terbinafine Normon, Vildagliptin/Metformin Cinfa, Levothyroxine sodium Teva, Paliperidone Teva, Venlafaxine Retard Viatris, Braftovi, Tobradex, and Zinnat.

Health sources indicate that in most instances, alternative medications with the same active ingredient, concentration, and administration route are available on the market. This means the absence of a specific presentation does not necessarily prevent patients from continuing their treatments. In certain cases, the AEMPS has authorized exceptional commercialization for products like Metoclopramide Basi, Novothirteen, or Braftovi.

In Galicia, the Galician Health Service (Sergas) has utilized a monitoring mechanism for over ten years to track medicine stocks in distribution warehouses. Developed in collaboration with pharmaceutical distributors, this system allows authorities to anticipate supply issues and implement measures based on the severity of each incident. Recovery timelines for shortages vary, with some expected by late November and others potentially delayed until 2027.

Entities

Galicia · Sergas · Spain · Spanish Agency for Medicines and Health Products